Welcome to our dedicated page for UBS ETRACS Alerian MLP ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding the filings of AMUB—UBS ETRACS Alerian MLP ETN Series B can feel like translating a bond prospectus and an energy-sector earnings call at the same time. Credit terms, fee adjustments and Alerian MLP Index re-balancing details are scattered across 10-K risk factors, 8-K material event notices and dense prospectus supplements. Tracking AMUB insider trading Form 4 transactions or pinpointing tax disclosures quickly becomes a full-time job.
Stock Titan solves that problem. Our AI distills every AMUB quarterly earnings report 10-Q filing into plain-English highlights, flags UBS credit-rating shifts and links each paragraph to the original page for context. Need real-time alerts? You’ll see AMUB Form 4 insider transactions in real-time the moment they hit EDGAR. The platform also provides side-by-side visuals that compare cash-distribution language across periods, making AMUB annual report 10-K simplified and searchable.
Whether you’re monitoring AMUB executive stock transactions Form 4, searching “AMUB proxy statement executive compensation,” or just want AMUB 8-K material events explained, every document is updated immediately and paired with machine-generated sentiment and peer benchmarks. Common questions like “AMUB SEC filings explained simply” or “understanding AMUB SEC documents with AI” are answered within minutes, letting you focus on decisions—not data hunting.
- AI-powered summaries and red-flag alerts
- Comprehensive coverage of all forms, from 424B2 prospectuses to 10-Qs
- Downloadable tables for distribution yields and index weightings
Skip the 200-page PDFs—get the AMUB earnings report filing analysis investors actually use.
UBS AG is offering Trigger Autocallable Yield Notes linked to the common stock of Constellation Energy Corporation, maturing on December 20, 2027. Each Note has a $1,000 principal amount and pays a fixed coupon at 11.15% per annum, with monthly payments as long as the Notes remain outstanding.
The Notes can be automatically called any month after 12 months if Constellation’s stock closes at or above the call threshold, set at 100% of the initial level ($357.14). If called, investors receive $1,000 plus the coupon for that month and no further payments. If the Notes are not called and the final stock level on the valuation date is at or above the downside threshold of 55% of the initial level ($196.43), investors receive their full principal at maturity, plus the last coupon.
If the final stock level is below the downside threshold, repayment is reduced one-for-one with the stock’s percentage decline, so investors can lose a significant portion or all of their investment. The Notes do not pay dividends or allow participation in stock gains beyond coupons, will not be listed on an exchange, and all payments depend on the creditworthiness of UBS. The estimated initial value per Note is expected to be between $949.10 and $979.10, below the $1,000 issue price.
UBS AG is offering Step Down Trigger Autocallable Notes linked to the least performing of the Russell 2000® Index and the S&P 500® Index, maturing on or about December 24, 2030. Each Note has a $1,000 principal amount and a call return rate of 9.00% per annum, paid only if the Notes are automatically called. UBS will automatically call the Notes on quarterly observation dates, beginning after 12 months, if the closing level of each index is at or above its call threshold level, which starts at 100% of its initial level and steps down over time to 75.00% on the final valuation date.
If called, holders receive the call price (principal plus the applicable call return) and no further payments. If the Notes are not automatically called and the final level of any index is below its downside threshold of 75.00% of its initial level, the maturity payment is $1,000 × (1 + underlying return of the least performing index), so losses match the percentage decline and can reach a 100% loss of principal. The estimated initial value is expected between
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the worst performer of the S&P 500® Index and the Russell 2000® Index, maturing on or about June 27, 2029. Each Note has a $1,000 principal amount and pays a contingent coupon at a rate of 7.75% per annum only if, on a monthly observation date, both indices close at or above their coupon barriers, set at 70% of initial level.
The Notes can be automatically called monthly beginning after 9 months if both indices are at or above their call thresholds, set at 100% of initial level, in which case holders receive principal plus the applicable coupon and the product terminates. If not called and both final index levels are at or above their downside thresholds of 60% of initial level, investors receive principal back (with a final coupon only if barriers are met). If any index finishes below its downside threshold, repayment is reduced one-for-one with the worst index’s decline, and all principal can be lost.
The Notes are unsecured, unsubordinated UBS debt, not insured deposits, and all payments depend on UBS’s credit. They are not listed, secondary liquidity may be limited, and the estimated initial value on the trade date is expected between $955.50 and $985.50 per Note versus a $1,000 issue price, reflecting fees, hedging and UBS’s internal funding rate.
UBS AG is offering $1,195,000 of three-year Trigger Autocallable Contingent Yield Notes with Memory Interest linked to the common stock of Regeneron Pharmaceuticals, Inc. Each Note has a $1,000 principal amount and offers a contingent coupon at a rate of 10.25% per annum ($25.625 per quarter) if Regeneron’s share price on a quarterly observation date is at or above the coupon barrier of $489.20, which is 65% of the $752.62 initial level.
The Notes can be automatically called quarterly starting about six months after issuance if Regeneron closes at or above the call threshold of $752.62 (100% of the initial level), in which case investors receive principal plus any due and previously unpaid coupons and the Notes terminate. If not called and the final share price on December 15, 2028 is at or above the $489.20 downside threshold, investors receive full principal; if it is below, repayment is reduced one-for-one with the share’s decline, and all principal can be lost. Payments depend entirely on UBS’s credit; the Notes are unsecured, not insured, and have an estimated initial value of $968.80 per $1,000.
UBS AG is offering Capped Buffer GEARS, unsecured debt securities linked to the iShares MSCI EAFE ETF, maturing around December 21, 2028. Each Security has a $1,000 principal amount, offers 1.50x leveraged exposure to any positive ETF performance, but gains are capped at a 38.30% maximum gain, for a maximum payment of $1,383 per Security.
If the ETF is flat or down but not below 85% of its initial level at maturity, investors receive their full principal back. If the ETF falls below this downside threshold, losses exceed the 15% buffer and can reach almost the entire investment. The notes pay no interest, do not pass through ETF dividends, are not listed on an exchange, and all payments depend on the creditworthiness of UBS.
UBS AG is issuing $3,075,000 of Trigger Callable Yield Notes linked to the worst performer of the Russell 2000 Index and the S&P 500 Index, maturing on March 17, 2027. Each Note has a $10 principal amount and pays fixed monthly coupons at a 7.90% per annum rate, regardless of index performance, as long as the Note has not been called.
UBS may, at its discretion, call the Notes in whole on monthly call dates beginning after three months, paying back $10 per Note plus the applicable coupon; no further payments are then made. If the Notes are not called and on the final valuation date both indices are at or above their downside thresholds, set at 70% of their initial levels, investors receive full principal plus the final coupon. If either index finishes below its threshold, repayment of principal is reduced one‑for‑one with the negative return of the worst index, and investors can lose up to 100% of principal.
The Notes are unsecured, unsubordinated obligations of UBS AG, are not FDIC‑insured, and will not be listed on any exchange. The estimated initial value is $9.80 per $10 Note, reflecting fees, hedging and UBS’ internal funding rate, so secondary market prices may initially be below the issue price.
UBS AG is offering $100,000 Trigger Autocallable Contingent Yield Notes linked to the common stock of Palantir Technologies Inc., scheduled to mature on December 17, 2027. These notes pay a contingent coupon only on dates when Palantir’s closing price is at or above a specified coupon barrier; if the price is below that level on an observation date, no coupon is paid for that period.
The notes are automatically called if Palantir’s stock closes at or above the initial level on any observation date before the final valuation date, in which case investors receive the $10 principal per note plus any due coupon and no further payments. If the notes are not called and the final stock level is at or above a downside threshold, investors receive principal back; if it is below that threshold, the payoff falls in line with the stock’s decline and can drop to zero, resulting in a total loss of the investment. All payments depend on UBS’s creditworthiness, and the estimated initial value as of the trade date is $9.78.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to Palantir Technologies Inc. common stock, maturing around December 17, 2027. These unsecured notes pay a contingent coupon only if Palantir’s closing price on an observation date is at or above a specified coupon barrier, and they may be automatically called early if the stock closes at or above the initial level.
If the notes are not called and Palantir’s final level is at or above a downside threshold, investors receive the $10 principal per note at maturity; if it finishes below that threshold, repayment is reduced in line with the stock’s decline and can fall to zero, so investors can lose their entire investment.
The notes are subject to UBS credit risk, are not bank deposits or FDIC insured, will not be listed on an exchange, and are initially offered at $10 per note with a minimum investment of 100 notes; the estimated initial value per note on the trade date is expected to be between $9.47 and $9.72.
UBS AG is offering $350,000 of Trigger Autocallable Contingent Yield Notes linked to Micron Technology common stock, maturing on December 17, 2027. The notes pay contingent coupons only if Micron’s closing price on each observation date is at or above a coupon barrier, and they can be called early if the stock is at or above its initial level, returning principal plus any due coupon. If the notes are not called and Micron’s final level is at or above a downside threshold, investors receive the $10 principal per note; if it finishes below that threshold, repayment is reduced in line with the stock’s decline, up to a total loss of principal. All payments depend on UBS’s credit, the notes are not insured or exchange-listed, the minimum investment is 100 notes ($1,000), and the estimated initial value is $9.78 per $10 note as of the trade date.
UBS AG is offering $340,000 of Trigger Autocallable Contingent Yield Notes linked to Oracle Corporation common stock, maturing on December 17, 2027.
The notes pay contingent coupons only if Oracle’s closing price on an observation date is at or above a coupon barrier, and they are automatically called early if Oracle is at or above the initial level, returning principal plus that coupon.
If not called, investors receive principal at maturity only if Oracle is at or above a downside threshold; otherwise the payoff declines in line with Oracle, and all of the $10 per note principal can be lost. The minimum investment is 100 notes and the estimated initial value is $9.76 per note, with all payments subject to UBS’s creditworthiness.